PL3083660T3 - Sposób wytwarzania antygenu przeciwko grypie - Google Patents

Sposób wytwarzania antygenu przeciwko grypie

Info

Publication number
PL3083660T3
PL3083660T3 PL14830896.8T PL14830896T PL3083660T3 PL 3083660 T3 PL3083660 T3 PL 3083660T3 PL 14830896 T PL14830896 T PL 14830896T PL 3083660 T3 PL3083660 T3 PL 3083660T3
Authority
PL
Poland
Prior art keywords
influenza antigen
antigen production
production
influenza
antigen
Prior art date
Application number
PL14830896.8T
Other languages
English (en)
Inventor
Edyta Kopera
Krystyna Maria GRZELAK
Włodzimierz Wiktor ZAGÓRSKI-OSTOJA
Bogusław SZEWCZYK
Violetta Teresa SĄCZYŃSKA
Katarzyna Natalia FLORYS
Violetta Cecuda-Adamczewska
Agnieszka Katarzyna Macioła
Maria Anna PIETRZAK
Konrad ZDANOWSKI
Original Assignee
Instytut Biochemii I Biofizyki Pan
Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Im. Prof. Ignacego Mościckiego
Uniwersytet Gdański
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Biochemii I Biofizyki Pan, Sieć Badawcza Łukasiewicz - Instytut Chemii Przemysłowej Im. Prof. Ignacego Mościckiego, Uniwersytet Gdański filed Critical Instytut Biochemii I Biofizyki Pan
Publication of PL3083660T3 publication Critical patent/PL3083660T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL14830896.8T 2013-12-20 2014-12-19 Sposób wytwarzania antygenu przeciwko grypie PL3083660T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PL406631A PL238555B1 (pl) 2013-12-20 2013-12-20 Sposób wytwarzania hydrofilowej domeny hemaglutyniny wirusa H5
PCT/PL2014/000148 WO2015093996A1 (en) 2013-12-20 2014-12-19 Antigen, influenza vaccine, system for vaccine manufacturing, method of antigen production, and use of antigen to produce an influenza vaccine

Publications (1)

Publication Number Publication Date
PL3083660T3 true PL3083660T3 (pl) 2021-02-22

Family

ID=52424083

Family Applications (2)

Application Number Title Priority Date Filing Date
PL406631A PL238555B1 (pl) 2013-12-20 2013-12-20 Sposób wytwarzania hydrofilowej domeny hemaglutyniny wirusa H5
PL14830896.8T PL3083660T3 (pl) 2013-12-20 2014-12-19 Sposób wytwarzania antygenu przeciwko grypie

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL406631A PL238555B1 (pl) 2013-12-20 2013-12-20 Sposób wytwarzania hydrofilowej domeny hemaglutyniny wirusa H5

Country Status (3)

Country Link
EP (1) EP3083660B1 (pl)
PL (2) PL238555B1 (pl)
WO (1) WO2015093996A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL235555B1 (pl) * 2014-06-24 2020-09-07 Inst Biotechnologii I Antybiotykow Wyizolowany i oczyszczony polipeptyd hemaglutyniny (HA ) wirusa grypy H5N1, kompozycja zawierająca polipeptyd i jej zastosowanie, przeciwciało wiążące się specyficznie z polipeptydem oraz sposób otrzymywania tego polipeptydu
PL422982A1 (pl) * 2017-09-26 2019-04-08 Instytut Biochemii I Biofizyki Polskiej Akademii Nauk Antygen uniwersalny, uniwersalna szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu i zastosowanie antygenu do wytwarzania szczepionki uniwersalnej przeciwko grypie

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006279323B2 (en) * 2005-08-16 2013-08-01 Merck Sharp & Dohme Corp. Influenza recombinant subunit vaccine
US20070286873A1 (en) * 2006-05-23 2007-12-13 Williams John V Recombinant Influenza H5 Hemagluttinin Protein And Nucleic Acid Coding Therefor
CN107281478B (zh) * 2010-07-23 2022-04-01 诺瓦瓦克斯公司 流感疫苗
PL220281B1 (pl) * 2011-09-23 2015-09-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA

Also Published As

Publication number Publication date
EP3083660A1 (en) 2016-10-26
PL238555B1 (pl) 2021-09-06
PL406631A1 (pl) 2015-06-22
EP3083660B1 (en) 2020-02-12
WO2015093996A1 (en) 2015-06-25

Similar Documents

Publication Publication Date Title
SG11201506284RA (en) Method of producing microparticles
GB201401248D0 (en) Method of manufacture
GB201517764D0 (en) Simulation of production systems
IL239737A0 (en) Method for protein production
SI3043814T1 (sl) Antigen in postopek za proizvodnjo le-tega
EP2960338A4 (en) SUGAR SOLUTION PROCESS
PL3071969T3 (pl) Sposób analizy
EP2952895A4 (en) PROCESS FOR PRODUCING A MARKED ANTIBODY
GB201322931D0 (en) Method of etching
SG11201508204RA (en) Method of producing semiconductor device
GB201305231D0 (en) Method of Manufacture
EP2953153A4 (en) PROCESS FOR PRODUCING SILICON WAFER ON INSULATION AND SILICON WAFER ON INSULATION
SG11201510639QA (en) Method of producing bonded wafer
EP2868476A4 (en) PROCESS FOR PRODUCING PRINTED MEDIA
SG11201601014WA (en) Method of producing bonded wafer
GB201305695D0 (en) A method of forming an article
PL3083660T3 (pl) Sposób wytwarzania antygenu przeciwko grypie
GB2515631B (en) Method of fabricating diodes
EP2786402B8 (en) Method of mechanosynthetic manufacture
EP2987038A4 (en) OPTIMIZATION OF A PROCESS
HK1216419A1 (zh) 合成方法
HK1208864A1 (en) A preparation method of ecteinascidin-743 intermediate -743
EP2976315A4 (en) PROCESS FOR THE PREPARATION OF C5-DI OLEFINES
GB2517480B (en) Method of producing a concrete article
EP2963020A4 (en) NOVEL CONNECTION, MANUFACTURING METHOD AND USE OF THE SAID CONNECTION